Literature DB >> 7528771

Receptor-induced death in human natural killer cells: involvement of CD16.

J R Ortaldo1, A T Mason, J J O'Shea.   

Abstract

Propriocidal regulation of T cells refers to apoptosis induced by interleukin 2 (IL-2) activation with subsequent antigen receptor stimulation. We examined whether natural killer (NK) cells exhibited cytokine- and ligand-induced death similar to activated T cells. Peripheral NK cells were examined for ligand-induced death using antibodies to surface moieties (CD2, CD3, CD8, CD16, CD56), with and without prior activation of IL-2. Only those NK cells stimulated first with IL-2 and then with CD16 exhibited ligand-induced death; none of the other antibody stimuli induced this phenomenon. Next we examined various cytokines (IL-2, IL-4, IL-6, IL-7, IL-12, IL-13, interferon alpha and gamma) that can activate NK cells and determined if CD16-induced killing occurred. Only IL-2 and IL-12 induced NK cell death after occupancy of this receptor by aggregated immunoglobulin or by cross-linking with antireceptor antibody. The CD16-induced death was inhibited by herbimycin A, indicating that cell death was dependent upon protein tyrosine kinases. Identical to T cells, the form of cell death for NK cells was demonstrated to be receptor-induced apoptosis. Overall these data indicate that highly activated NK cells mediate ligand-induced apoptosis via signaling molecules like CD16. Whereas the propriocidal regulation of T cells is antigen specific, this is not the case for NK cells due to the nature of the receptor. The clinical implications of this finding are considered.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7528771      PMCID: PMC2191809          DOI: 10.1084/jem.181.1.339

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  22 in total

1.  Expression of the APO-1 antigen in Burkitt lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotype.

Authors:  M H Falk; B C Trauth; K M Debatin; C Klas; C D Gregory; A B Rickinson; A Calender; G M Lenoir; J W Ellwart; P H Krammer
Journal:  Blood       Date:  1992-06-15       Impact factor: 22.113

Review 2.  Structure and function of the CD16:zeta:gamma complex expressed on human natural-killer cells.

Authors:  E Vivier; M Ackerly; N Rochet; P Anderson
Journal:  Int J Cancer Suppl       Date:  1992

Review 3.  Signaling for death of lymphoid cells.

Authors:  L B King; J D Ashwell
Journal:  Curr Opin Immunol       Date:  1993-06       Impact factor: 7.486

4.  Differential expression of APO-1 on human thymocytes: implications for negative selection?

Authors:  K M Debatin; D Süss; P H Krammer
Journal:  Eur J Immunol       Date:  1994-03       Impact factor: 5.532

5.  T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis.

Authors:  J M Critchfield; M K Racke; J C Zúñiga-Pflücker; B Cannella; C S Raine; J Goverman; M J Lenardo
Journal:  Science       Date:  1994-02-25       Impact factor: 47.728

6.  Detection of DNA fragmentation in apoptosis: application of in situ nick translation to cell culture systems and tissue sections.

Authors:  R Gold; M Schmied; G Rothe; H Zischler; H Breitschopf; H Wekerle; H Lassmann
Journal:  J Histochem Cytochem       Date:  1993-07       Impact factor: 2.479

7.  Propriocidal apoptosis of mature T lymphocytes occurs at S phase of the cell cycle.

Authors:  S A Boehme; M J Lenardo
Journal:  Eur J Immunol       Date:  1993-07       Impact factor: 5.532

8.  Isolation of human and rat natural killer cells.

Authors:  T Timonen; C W Reynolds; J R Ortaldo; R B Herberman
Journal:  J Immunol Methods       Date:  1982       Impact factor: 2.303

9.  Purification and characterization of the Fas-ligand that induces apoptosis.

Authors:  T Suda; S Nagata
Journal:  J Exp Med       Date:  1994-03-01       Impact factor: 14.307

10.  Human natural killer cells isolated from peripheral blood do not rearrange T cell antigen receptor beta chain genes.

Authors:  L L Lanier; S Cwirla; N Federspiel; J H Phillips
Journal:  J Exp Med       Date:  1986-01-01       Impact factor: 14.307

View more
  27 in total

1.  IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells.

Authors:  Robin Parihar; Julie Dierksheide; Yan Hu; William E Carson
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

2.  A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease.

Authors:  J Wu; J C Edberg; P B Redecha; V Bansal; P M Guyre; K Coleman; J E Salmon; R P Kimberly
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

3.  CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset.

Authors:  Sandra Lopez-Vergès; Jeffrey M Milush; Suchitra Pandey; Vanessa A York; Janice Arakawa-Hoyt; Hanspeter Pircher; Philip J Norris; Douglas F Nixon; Lewis L Lanier
Journal:  Blood       Date:  2010-08-23       Impact factor: 22.113

4.  Dynamic changes in the numbers of different subsets of peripheral blood NK cells in patients with systemic lupus erythematosus following classic therapy.

Authors:  Hongshuang Ma; Ling Zhao; Zhenyu Jiang; Yanfang Jiang; Li Feng; Zhuang Ye
Journal:  Clin Rheumatol       Date:  2014-07-15       Impact factor: 2.980

5.  Rescue of thymocytes from glucocorticoid-induced cell death mediated by CD28/CTLA-4 costimulatory interactions with B7-1/B7-2.

Authors:  D H Wagner; J Hagman; P S Linsley; W Hodsdon; J H Freed; M K Newell
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

6.  Blood natural killer cell deficiency reveals an immunotherapy strategy for atopic dermatitis.

Authors:  Madison R Mack; Jonathan R Brestoff; Melissa M Berrien-Elliott; Anna M Trier; Ting-Lin B Yang; Matthew McCullen; Patrick L Collins; Haixia Niu; Nancy D Bodet; Julia A Wagner; Eugene Park; Amy Z Xu; Fang Wang; Rebecca Chibnall; M Laurin Council; Carrie Heffington; Friederike Kreisel; David J Margolis; David Sheinbein; Paola Lovato; Eric Vivier; Marina Cella; Marco Colonna; Wayne M Yokoyama; Eugene M Oltz; Todd A Fehniger; Brian S Kim
Journal:  Sci Transl Med       Date:  2020-02-26       Impact factor: 17.956

7.  Changes in immune cell frequencies after cyclophosphamide or mycophenolate mofetil treatments in patients with systemic lupus erythematosus.

Authors:  Ling Zhao; Zhenyu Jiang; Yanfang Jiang; Ning Ma; Kai Wang; Yandong Zhang
Journal:  Clin Rheumatol       Date:  2012-02-21       Impact factor: 2.980

8.  Simian immunodeficiency virus (SIV)/immunoglobulin G immune complexes in SIV-infected macaques block detection of CD16 but not cytolytic activity of natural killer cells.

Authors:  Qing Wei; Jackie W Stallworth; Patricia J Vance; James A Hoxie; Patricia N Fultz
Journal:  Clin Vaccine Immunol       Date:  2006-07

9.  Epigenetic and Posttranscriptional Regulation of CD16 Expression during Human NK Cell Development.

Authors:  Aaron R Victor; Christoph Weigel; Steven D Scoville; Wing Keung Chan; Kelsey Chatman; Mary M Nemer; Charlene Mao; Karen A Young; Jianying Zhang; Jianhua Yu; Aharon G Freud; Christopher C Oakes; Michael A Caligiuri
Journal:  J Immunol       Date:  2017-12-11       Impact factor: 5.422

Review 10.  Endocytosis and intracellular trafficking of human natural killer cell receptors.

Authors:  Madhan Masilamani; Giovanna Peruzzi; Francisco Borrego; John E Coligan
Journal:  Traffic       Date:  2009-08-05       Impact factor: 6.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.